New patent expiration for Mallinckrodt Hosp drug OFIRMEV

Annual Drug Patent Expirations for OFIRMEV Ofirmev is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from two suppliers. There are five patents…
The post New patent expiration for Mallinckrodt Hosp drug OFIRMEV appeare…


Which pharmaceutical companies have the most implant dosed drugs?

This chart shows the pharmaceutical companies with the most implant dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most implant dosed drugs…
The post Which pharmaceutical companies have the most impl…


Biotechblog